Deltex Medical Group
Deltex Medical Group plc is a UK-listed medical device company that develops and sells proprietary hemodynamic monitoring technology for real-time blood flow and cardiovascular measurement in surgical and critical care settings, serving hospitals, surgical centers, and critical care units.
- Company typePublic
- Founded2000
- HeadquartersChichester, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Deltex Medical Group does
Deltex Medical Group plc is a UK-based publicly listed medical device company (LSE: DEMG) founded in 2000 and headquartered in Chichester, England, with 51-100 employees. The company develops and commercializes hemodynamic monitoring technology that measures and analyzes blood flow and cardiovascular parameters in real time, targeting surgical and critical care clinical settings. Its portfolio is built around a core hemodynamic monitoring platform used by hospitals, surgical centers, and critical care units to optimize patient circulatory management during procedures and in intensive care.
The company's revenue model is not publicly disclosed in terms of pricing or unit economics; as a medical device vendor its income is generated through sales of monitoring hardware and associated consumables into healthcare procurement channels, primarily serving hospitals and surgical centers (its primary customer segments). The product's stated differentiator is accuracy and precision in hemodynamic measurement, and the company competes on domain specialization in surgical and critical care monitoring. Prior portfolio expansion includes the 2006 acquisition of Medicina's TECO.
Operationally, the company has faced financial pressure: in July 2023 it conditionally raised approximately GBP 1.7 million via a share placing and subscription (with up to an additional GBP 500,000 via retail offer to existing shareholders), with proceeds earmarked for working capital, restructuring costs, creditor payments, and strategic updates. Leadership includes founder Pauline Thomas, Chairman Edwin Snape, and a combined COO/Chief Scientific Officer role held by Graham Lowe.
Deltex Medical Group firmographics
Firmographics- Name
- Deltex Medical Group
- Legal name
- Deltex Medical Group plc
- Website
- https://deltexmedical.com
- Company type
- Public
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Deltex Medical Group plc is a UK-listed medical device company that develops and sells proprietary hemodynamic monitoring technology for real-time blood flow and cardiovascular measurement in surgical and critical care settings, serving hospitals, surgical centers, and critical care units.
- Ownership category
- akta.pro rank
Deltex Medical Group industry classification
Industry- Product category
- Hemodynamic Monitoring Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
- akta.pro secondary industry
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
Keywords
Where Deltex Medical Group is headquartered
LocationHeadquarters
- HQ city
- Chichester
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Deltex Medical Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Deltex Medical Group product offering
Product offeringCore offering
Deltex Medical Group plc develops and sells hemodynamic monitoring medical device technology used in surgical and critical care applications. Its core product is a hemodynamic monitoring platform that enables real-time measurement and analysis of blood flow and cardiovascular parameters to help clinicians assess and manage patients' circulatory status during surgery and in intensive care.
Product overview
Deltex Medical Group offers a hemodynamic monitoring technology platform designed for surgical and critical care medical applications. The company's core product is its hemodynamic monitoring technology, which enables real-time measurement and analysis of blood flow and cardiovascular parameters during medical procedures. The portfolio consists of specialized monitoring devices and associated technology for surgical and intensive care settings.
Differentiator
Problem solved
Functional benefit
Products and services
- Hemodynamic Monitoring Technology Medical device technology for hemodynamic monitoring used in surgical and critical care applications to measure and analyze blood flow and cardiovascular parameters. Targeted at hospitals, surgical centers, and critical care units needing real-time circulatory status information to improve patient outcomes.
Companies that use Deltex Medical Group
Customer profileSegments2 records
Ideal customer profiles1 record
Deltex Medical Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Deltex Medical Group partnerships and signals
Strategic signalScale indicators3 records
Recent moves4 records
Expansion highlights3 records
Deltex Medical Group competitors and assessment
Company assessmentMarket position
Competitive moat3 records
Key highlights5 records
Customer concentration
Deltex Medical Group social profiles
Digital presenceDeltex Medical Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Deltex Medical Group leadership team
Management profileNumber of profiles
Profiles3 records
Deltex Medical Group funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Deltex Medical Group M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Deltex Medical Group
What does Deltex Medical Group do?
Deltex Medical Group plc develops and sells hemodynamic monitoring medical device technology used in surgical and critical care applications. Its core product is a hemodynamic monitoring platform that enables real-time measurement and analysis of blood flow and cardiovascular parameters to help clinicians assess and manage patients' circulatory status during surgery and in intensive care.
Is Deltex Medical Group a public or private company?
Deltex Medical Group is a public company. It is classified as public and is currently operating.
When was Deltex Medical Group founded?
Deltex Medical Group was founded in 2000. It employs 51 to 100 people.
Where is Deltex Medical Group based?
Deltex Medical Group is headquartered in Chichester, United Kingdom, in the Europe region.
Does Deltex Medical Group have an API?
No public API is recorded for Deltex Medical Group.
What industry is Deltex Medical Group in?
Deltex Medical Group's product category is Hemodynamic Monitoring Medical Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.